Personal genomics player Helix has launched an online marketplace for “DNA-powered products,” including Sema4's saliva-based carrier test from Sema4.

Celgene has announced a new arm of a phase 1b study that will study Novocure’s noninvasive brain cancer therapy alongside a pair of cancer drugs.

The latest deal sees Alere agree to sell its Epocal point-of-care blood diagnostic unit to Siemens for an undisclosed sum.

Aspect Imaging has earned an FDA nod for its neonatal magnetic resonance imaging (MRI) device, designed for head and brain imaging in neonatal intensive care…

The series B round equips Amphora to take its minimally invasive, cystoscopic device into the last step of clinical development next year.

Mayo Clinic and AliveCor are developing a low-cost, portable screening tool for long QT, which can cause sudden cardiac death.

Simplify Medical raised $21 million in series B funding to support two U.S. pivotal trials of its nonmetal cervical artificial disc.

Voluntis picked up U.S. and EU nods to integrate Sanofi's Toujeo into its basal insulin management app and plans to add more.

Quest Diagnostics has completed its acquisition of a pair of laboratory businesses in Texas, establishing a foothold in the southwestern U.S.